 |
(Natural News) There was a lot of hope when early reports indicated that the drug Remdesivir was helping some coronavirus patients, but a closer look at the clinical trial reveals that its effects are minimal, if any. In fact, all it accomplished was a slight decrease in “time until clinical recovery.” So why is this... |
Remdesivir is "probably worthless"... trials rigged to gain FDA-granted 7-year monopoly
Continue Reading
Bagikan Berita Ini
0 Response to "Remdesivir is "probably worthless"... trials rigged to gain FDA-granted 7-year monopoly"
Post a Comment